A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 26, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions
Atopic DermatitisEczema
Interventions
DRUG

HAT01H Cream

HAT01H Cream will be applied twice daily. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.

DRUG

Vehicle Cream

Vehicle Cream will be applied twice daily. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.

Trial Locations (1)

Unknown

Clinical Research Pvt Ltd, Bangalore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Haus Bioceuticals

INDUSTRY

NCT03089229 - A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis | Biotech Hunter | Biotech Hunter